On Demand | Medical Management of Endogenous Cushing’s Syndrome
(5)
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Course Description
  • Learning Objectives
  • Accreditation and Credit Claim Instructions
  • Faculty and Disclosures
  • Recommended

This is the recording of a of live event; this course was designed for regional experts in pituitary care to present live, in-person using interactive case-based discussion which will benefit clinicians to better manage and monitor response to treatment of Cushing's Disease. During this educational event, attendees will learn about recent advances in managing Cushing’s Syndrome and its complications and enable caregivers to improve their ability to identify and manage the condition accurately. 

The live interactive case-based discussion format will help attendees better understand the role of individualized treatment, including surgery, medical therapy, bilateral adrenalectomy and radiation. We will focus on recently approved second-line treatment therapies tailored to meet unique patient needs, including the best biochemical markers, for assessing treatment response. This will optimize medical therapy treatment outcomes for patients and improve their quality of life. Participation will help attendees learn how to distinguish features of glucocorticoid withdrawal from adrenal insufficiency, which can be somewhat difficult to differentiate clinically. Understanding these differences can help clinicians make informed decisions regarding patient management.

The program will review the importance of comorbidities and symptoms management in patients with hypercortisolemia due to an ACTH-secreting pituitary adenoma. This can be especially important, as patients with Cushing's Disease experience a range of physical and emotional symptoms that adversely impact their quality of life.

  1. Understand the importance of biochemical control and interpretation of laboratory results for Cushing’s syndrome.
  2. Assess patient selection for individualized second- line therapies for Cushing’s disease: repeat surgery, medication, radiation, and bilateral adrenalectomy.
  3. Review risks and benefits of medical therapy to optimize treatment outcomes for patients with Cushing’s disease.
  4. dentify features of glucocorticoid withdrawal and learn to distinguish its diagnosis and management from adrenal insufficiency.
  5. Discuss importance of co-morbidity and symptom management in patients with Cushing’s syndrome.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Endocrine Society and the American College of Osteopathic Family Physicians. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians. 

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

 

Eliza Geer, MD
Associate Professor
Memorial Sloan Kettering

Disclosures:

  • Advisory Board - Strongbridge/Xeris; HRA Pharma; Chiasma/Amryt
  • Grant Recipient - Strongbridge/Xeris; Sparrow; Corcept; Recordati; Ionis
  • Consultant - Strongbridge/Xeris

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. Faculty List and Disclosures

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.


ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by educational grant from Recordati

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By